CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer
Open accessPublished version of a preprint
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Immune checkpoint inhibitors (ICIs) have completely changed the approach pertaining to tumor diagnostics and treatment. Similarly, immunotherapy has also provided much needed data about mutation, expression and prognosis, affording an unprecedented opportunity for discovering candidate drug targets and screening for immunotherapy-relevant biomarkers. Although existing web tools enable biologists to analyze the expression, mutation and prognostic data of tumors, they are currently unable to facilitate data mining and mechanism analyses specifically related to immunotherapy. Thus, we effectively developed our own web-based tool, called Comprehensive Analysis on Multi-Omics of Immunotherapy in Pan-cancer (CAMOIP), in which we are able to successfully screen various prognostic markers and analyze the mechanisms involved in biomarker expression and function, as well as immunotherapy. The analyses include information relevant to survival analysis, expression analysis, mutational landscape analysis, immune infiltration analysis, immunogenicity analysis and pathway enrichment analysis. This comprehensive analysis of biomarkers for immunotherapy can be carried out by a click of CAMOIP, and the software should greatly encourage the further development of immunotherapy. CAMOIP provides invaluable evidence that bridges the information between the data of cancer genomics based on immunotherapy, providing comprehensive information to users and assisting in making the value of current ICI-treated data available to all users. CAMOIP is available at https://www.camoip.net.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationTGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Tang, Z., Kang, B., Li, C., Chen, T., & Zhang, Z. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz430 · Cited by 5,083
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
Visualizing and interpreting cancer genomics data via the Xena platform
Goldman, M. J., Craft, B., Hastie, M., Repečka, K., McDade, F., Kamath, A., Banerjee, A., Luo, Y., Rogers, D., Brooks, A. N., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0546-8 · Cited by 4,481
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Colaprico, A., Silva, T. C., Olsen, C., Garofano, L., Cava, C., Garolini, D., Sabedot, T. S., Malta, T. M., Pagnotta, S. M., Castiglioni, I., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1507 · Cited by 4,183
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Samstein, R. M., Lee, C.-H., Shoushtari, A. N., Hellmann, M. D., Shen, R., Janjigian, Y. Y., Barron, D. A., Zehir, A., Jordan, E. J., Omuro, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0312-8 · Cited by 4,071
Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
Profiling Tumor Infiltrating Immune Cells with CIBERSORT
Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M., & Alizadeh, A. A. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7493-1_12 · Cited by 3,874
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Becht, E., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Selves, J., Laurent-Puig, P., Sautès-Fridman, C., Fridman, W. H., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1070-5 · Cited by 3,685
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448
Tumor mutational burden and response rate to PD-1 inhibition
Yarchoan, M., Hopkins, A., & Jaffee, E. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1713444 · Cited by 3,230
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Riaz, N., Havel, J. J., Makarov, V., Desrichard, A., Urba, W. J., Sims, J. S., Hodi, F. S., Martín-Algarra, S., Mandal, R., Sharfman, W. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.028 · Cited by 2,401
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Landscape of Microsatellite Instability Across 39 Cancer Types
Bonneville, R., Krook, M. A., Kautto, E. A., Miya, J., Wing, M. R., Chen, H.-Z., Reeser, J. W., Yu, L., & Roychowdhury, S. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00073 · Cited by 1,476
Rizvi, H., Sanchez-Vega, F., La, K., Chatila, W., Jonsson, P., Halpenny, D., Plodkowski, A., Long, N., Sauter, J. L., Rekhtman, N., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.3384 · Cited by 1,367
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
Auslander, N., Zhang, G., Lee, J. S., Frederick, D. T., Miao, B., Moll, T., Tian, T., Wei, Z., Madan, S., Sullivan, R. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0157-9 · Cited by 738
Repana, D., Nulsen, J., Dressler, L., Bortolomeazzi, M., Venkata, S. K., Tourna, A., Yakovleva, A., Palmieri, T., & Ciccarelli, F. D. (2019) · Genome Biology · doi:10.1186/s13059-018-1612-0 · Cited by 674
EPIC: A Tool to Estimate the Proportions of Different Cell Types from Bulk Gene Expression Data
Racle, J., & Gfeller, D. (2020) · Methods in Molecular Biology · doi:10.1007/978-1-0716-0327-7_17 · Cited by 554
Petryszak, R., Keays, M., Tang, Y. A., Fonseca, N. A., Barrera, E., Burdett, T., Füllgrabe, A., Fuentes, A. M.-P., Jupp, S., Koskinen, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1045 · Cited by 530
Prat, A., Navarro, A., Paré, L., Reguart, N., Galván, P., Pascual, T., Martínez, A., Nuciforo, P., Comerma, L., Alos, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3556 · Cited by 455
The UCSC Xena platform for public and private cancer genomics data visualization and interpretation
Goldman, M., Craft, B., Hastie, M., Repečka, K., Kamath, A., McDade, F., Rogers, D., Brooks, A. N., Zhu, J., & Haussler, D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/326470 · Cited by 448
Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
Ulloa-Montoya, F., Louahed, J., Dizier, B., Gruselle, O., Spiessens, B., Lehmann, F. F., Suciu, S., Kruit, W. H. J., Eggermont, A. M. M., Vansteenkiste, J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.3762 · Cited by 436
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer
Lin, A., Zhang, J., & Luo, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02039 · Cited by 358
Self-citationThe NCI Genomic Data Commons as an engine for precision medicine
Jensen, M. A., Ferretti, V., Grossman, R. L., & Staudt, L. M. (2017) · Blood · doi:10.1182/blood-2017-03-735654 · Cited by 324
Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq
(2020) · Methods in Enzymology · doi:10.1016/bs.mie.2019.05.056 · Cited by 269
Methods of measurement for tumor mutational burden in tumor tissue
Meléndez, B., Van Campenhout, C., Rorive, S., Remmelink, M., Salmon, I., & D’Haene, N. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.08.02 · Cited by 233
Hwang, S., Kwon, A.-Y., Jeong, J.-Y., Kim, S., Kang, H., Park, J., Kim, J.-H., Han, O. J., Lim, S. M., & An, H. J. (2020) · Scientific Reports · doi:10.1038/s41598-019-57218-9 · Cited by 215
Sui, S., An, X., Xu, C., Li, Z., Hua, Y., Huang, G., Sui, S., Long, Q., Sui, Y., Xiong, Y., et al. (2020) · Theranostics · doi:10.7150/thno.49451 · Cited by 158
Self-citationGene Set Enrichment Analysis (GSEA) for Interpreting Gene Expression Profiles
Shi, J., & Walker, M. (2007) · Current Bioinformatics · doi:10.2174/157489307780618231 · Cited by 141
Zhang, J., Zhou, N., Lin, A., Luo, P., Chen, X., Deng, H., Kang, S., Guo, L., Zhu, W., & Zhang, J. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02668-8 · Cited by 125
Self-citationEndris, V., Buchhalter, I., Allgäuer, M., Rempel, E., Lier, A., Volckmar, A., Kirchner, M., von Winterfeld, M., Leichsenring, J., Neumann, O., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32002 · Cited by 105
Mino-Kenudson, M. A. (2016) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0009 · Cited by 103
Dolled-Filhart, M., Locke, D., Murphy, T., Lynch, F., Yearley, J. H., Frisman, D., Pierce, R., Weiner, R., Wu, D., & Emancipator, K. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0544-oa · Cited by 92
Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases
Warth, A., Körner, S., Penzel, R., Muley, T., Dienemann, H., Schirmacher, P., Doeberitz, M. V. K., Weichert, W., & Kloor, M. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1892-7 · Cited by 77
Web Application Teaching Tools for Statistics Using R and Shiny
Doi, J. A., Potter, G. L., WONG, J., ALCARAZ, I., & CHI, P. (2016) · Technology Innovations in Statistics Education · doi:10.5070/t591027492 · Cited by 77
Lin, A., Zhang, H., Hu, X., Chen, X., Wu, G., Luo, P., & Zhang, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105028 · Cited by 60
Self-citationPrognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
Niu, Y., Lin, A., Luo, P., Zhu, W., Wei, T., Tang, R., Guo, L., & Zhang, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01213 · Cited by 53
Self-citationLin, A., Qiu, Z., Zhang, J., & Luo, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630773 · Cited by 45
Self-citationLyu, Q., Lin, A., Cao, M., Xu, A., Luo, P., & Zhang, J. (2020) · Cancer Control · doi:10.1177/1073274820976665 · Cited by 40
Self-citationHuang, X., Tang, T., Zhang, G., Hong, Z., Xu, J., Yadav, D. K., Bai, X., & Liang, T. (2020) · npj Precision Oncology · doi:10.1038/s41698-020-00136-1 · Cited by 13
Biomarkers for neoadjuvant checkpoint blockade response in urothelial cancer
Ghatalia, P., & Plimack, E. R. (2019) · Nature Medicine · doi:10.1038/s41591-019-0645-6 · Cited by 9
Yang, W., Lin, A., Zhu, W., Wei, T., Luo, P., Guo, L., & Zhang, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.645862 · Cited by 9
Self-citation
Cited by
Liu, C.-J., Hu, F.-F., Xie, G.-Y., Miao, Y.-R., Li, X.-W., Zeng, Y., & Guo, A.-Y. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbac558 · Cited by 588
TIMER3: an enhanced resource for tumor immune analysis
Cui, H., Zhao, G., Lu, Y., Zuo, S., Duan, D., Luo, X., Zhao, H., Li, J., Zeng, Z., Chen, Q., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf388 · Cited by 144
“Resources such as CAMOIP, CancerImmu-nityQTL, GSCA, GEPIA, TIGER, and TIMEDB each offer unique strengths in areas including immune infiltration analysis, genetic variation, and immunotherapy [ 14–19 ].”
Lin, A., Xiong, M., Jiang, A., Huang, L., Wong, H. Z. H., Feng, S., Zhang, C., Yu, H., Chen, L., Chi, H., et al. (2025) · iMeta · doi:10.1002/imt2.70070 · Cited by 108
Self-citationWu, L., Sun, S., Qu, F., Sun, M., Liu, X., Sun, Q., Cheng, L., Zheng, Y., & Su, G. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03343-w · Cited by 49
Xie, W., Cheng, J. R., Hong, Z., Cai, W., Zhuo, H., Hou, J., Lin, L., Wei, X., Wang, K., Chen, X., et al. (2022) · Cancers · doi:10.3390/cancers15010164 · Cited by 55
“We also used CAMOIP [21] (http:/camoip.”
Metadata
- Authors
- Lin, A., Qi, C., Wei, T., Li, M., Cheng, Q., Liu, Z., Luo, P., & Zhang, J.
- Affiliations
- Zhujiang Hospital (CN)
- Central South University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Corresponding author
- Luo, Peng
- Zhang, Jian
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-04-09
- Volume
- 23
- Issue
- 3
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W4225957066
- Semantic Scholar
- 112f9aa2b6cb6450112c3508adb1124e22c2697d
- Cited by
- 152
- References
- 51
- Citations by year
- 2026: 13 · 2025: 34 · 2024: 37 · 2023: 42 · 2022: 26
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Briefings in Bioinformatics (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Guangdong Province (2018A030313846, 2021A1515012593)
- Science and Technology Planning Project of Guangdong Province (2019A030317020)
- National Natural Science Foundation of China (81802257, 81871859, 81772457, 82172750, 82172811)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- immune checkpoint inhibitors, immunotherapy, pan-cancer, multi-omics integration, prognostic factors, immune cell infiltration, mutational landscape, immunogenicity, pathway enrichment, survival analysis, web server, cancer genomics
- MeSH terms
- Immune Checkpoint Inhibitors, Humans, Immunotherapy, Mutation, Neoplasms, Biomarkers, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.